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Abstract
Avian paramyxoviruses (APMVs) are frequently isolated from domestic and wild birds throughout the world and are
separated into nine serotypes (APMV-1 to -9). Only in the case of APMV-1, the infection of non-avian species has
been investigated. The APMVs presently are being considered as human vaccine vectors. In this study, we
evaluated the replication and pathogenicity of all nine APMV serotypes in hamsters. The hamsters were inoculated
intranasally with each virus and monitored for clinical disease, pathology, histopathology, virus replication, and
seroconversion. On the basis of one or more of these criteria, each of the APMV serotypes was found to replicate
in hamsters. The APMVs produced mild or inapparent clinical signs in hamsters except for APMV-9, which
produced moderate disease. Gross lesions were observed over the pulmonary surface of hamsters infected with
APMV-2 & -3, which showed petechial and ecchymotic hemorrhages, respectively. Replication of all of the APMVs
except APMV-5 was confirmed in the nasal turbinates and lungs, indicating a tropism for the respiratory tract.
Histologically, the infection resulted in lung lesions consistent with bronchointerstitial pneumonia of varying
severity and nasal turbinates with blunting or loss of cilia of the epithelium lining the nasal septa. The majority of
APMV-infected hamsters exhibited transient histological lesions that self resolved by 14 days post infection (dpi). All
of the hamsters infected with the APMVs produced serotype-specific HI or neutralizing antibodies, confirming virus
replication. Taken together, these results demonstrate that all nine known APMV serotypes are capable of
replicating in hamsters with minimal disease and pathology.
Introduction
Paramyxoviridae is a large and diverse family whose
members have been isolated from many species of
avian, terrestrial, and aquatic animal species around the
world [1]. Paramyxoviruses are pleomorphic, enveloped,
cytoplasmic viruses that have a non-segmented, nega-
tive-sense RNA genome. The family is divided into two
subfamilies, Paramyxovirinae and Pneumovirinae, based
on their structure, genome organization, and sequence
relatedness [2]. The subfamily Paramyxovirinae contains
five genera: Respirovirus, Rubulavirus, Morbillivirus,
Henipavirus, and Avulavirus, while the subfamily Pneu-
movirinae contains two genera, Pneumovirus and
Metapneumovirus [3]. All paramyxoviruses that have
been isolated to date from avian species can be segre-
gated into two genera based on the taxonomic criteria
mentioned above: genus Avulavirus, whose members are
called the avian paramyxoviruses (APMV), and genus
Metapneumovirus, whose members are called avian
metapneumoviruses. The APMV of genus Avulavirus
are separated into nine serotypes (APMV-1 through -9)
based on Hemagglutination Inhibition (HI) and Neura-
minidase Inhibition (NI) assays [4]. Various strains of
APMV-1, which is also called Newcastle disease virus
(NDV), have been analyzed in detail by biochemical ana-
lysis, genome sequencing, and pathogenesis studies, and
important molecular determinants of virulence have
been identified [5-9]. As a first step in characterizing the
other APMV serotypes, complete genome sequences of
one or more representative strains of APMV serotypes 2
to 9 were recently determined, expanding our knowl-
edge about these viruses [10-18].
APMV-1 comprises all strains of NDV and is the best
characterized serotype because of the severity of disease
caused by virulent NDV strains in chickens. NDV
strains vary greatly in their pathogenicity to chickens
and are grouped into three pathotypes: highly virulent
(velogenic) strains, which cause severe respiratory and
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neurological disease in chickens; moderately virulent
(mesogenic) strains, which cause mild disease; and non-
pathogenic (lentogenic) strains, which cause inapparent
infections. In contrast, very little is known about the
comparative disease potential of APMV-2 to APMV-9
in domestic and wild birds. APMV-2 strains have been
isolated from chickens, turkeys and wild birds across the
globe [4,19-22]. APMV-2 infections in turkeys have
been found to cause mild respiratory disease, decreases
in egg production, and infertility [23,24]. APMV-3
strains have been isolated from wild and domestic birds
[25]. APMV-3 infections have been associated with
encephalitis and high mortality in caged birds [26-28].
APMV-4 strains have been isolated from chickens,
ducks and geese [29]. Experimental infection of chickens
with APMV-4 resulted in mild interstitial pneumonia
and catarrhal tracheitis [30]. APMV-5 strains have only
been isolated from budgerigars (Melopsittacus undula-
tus) and cause depression, dyspnoea, diarrhea, torticollis,
and acute fatal enteritis in immature budgerigars, lead-
ing to very high mortality [31]. APMV-6 was first iso-
lated from a domestic duck and was found to cause
mild respiratory disease and drop in egg production in
turkeys, but was avirulent in chickens [10,30,32].
APMV-7 was first isolated from a hunter-killed dove
and has also been isolated from a natural outbreak of
respiratory disease in turkeys. APMV-7 infection in tur-
keys caused respiratory disease, mild multifocal nodular
lymphocytic airsacculitis, and decreased egg production
[33]. APMV-8 was isolated from a goose and a feral pin-
tail duck [34,35]. APMV-9 strains have been isolated
from ducks around the world [36,37]. APMV types -2,
-3, and -7 have been associated with mild respiratory
disease and egg production problems in domestic chick-
ens [33]. There are no reports of isolation of APMV-5,
-8 and -9 from poultry [32]. But recent serosurveillance
of commercial poultry farms in USA indicated the possi-
ble prevalence of all APMV serotypes excluding APMV-
5 in chickens [38].
APMV-1 (NDV) is known to replicate in non-avian
species including humans [39-44], although its only nat-
ural hosts are birds. APMV-1 infections in non-avian
species are usually asymptomatic or mild. Clinical signs
in human infections commonly involve conjunctivitis,
which usually is transient and self-limiting. Presently,
APMV-1 is being evaluated as a vaccine vector against
human pathogens [45]. When administered to the
respiratory tract of non-human primates, NDV is highly
restricted in replication, but foreign antigens expressed
by recombinant NDV vectors are moderately to highly
immunogenic. One of the major advantages of this
approach is that most humans do not have pre-existing
immunity to APMV-1. Pre-existing immunity is a
potential drawback to using vectors derived from
common human pathogens, and also can be a concern
for any vector if two or more doses are necessary to eli-
cit protective immunity. Therefore, we are investigating
APMV types 2 to 9, which are antigenically distinct
from APMV-1, as alternative human vaccine vectors.
Also, some of these additional APMV types likely will
have differences in replication, attenuation, and immu-
nogenicity compared to APMV-1 that may be advanta-
geous. However, the replication and pathogenicity of
APMV-2 to -9 in non-avian species has not been stu-
died. As a first step, we have evaluated the replication
and pathogenicity of APMV-2 to -9 in hamsters. In this
study, groups of hamsters were infected with a proto-
type strain of each APMV serotype by the intranasal
route and monitored for virus replication, clinical symp-
toms, histopathology, and seroconversion. Our results
showed that each of the APMV serotypes replicated in
hamsters without causing adverse clinical signs of ill-
ness, although histopathologic evidence of disease was




The following nine prototype strains of APMV serotypes
1 to 9 were used, APMV-1, NDV lentogenic strain
LaSota/46; APMV-2, APMV-2/Chicken/California/
Yucaipa/56; APMV-3, APMV-3/PKT/Netherland/449/
75; APMV-4, APMV-4/duck/HongKong/D3/75; APMV-
5, APMV-5/budgerigar/Kunitachi/74; APMV-6, APMV-
6/duck/HongKong/18/199/77; APMV-7, APMV-7/dove/
Tennessee/4/75; APMV-8, APMV-8/goose/Delaware/
1053/76; APMV-9, APMV-9/duck/New York/22/1978.
All of the viruses were grown in 9-day-old embryonated
specific-pathogen-free (SPF) chicken eggs inoculated by
the allantoic route, except for APMV-5, which was
grown in African green monkey kidney (Vero) cells
(ATCC, Manassas, VA, USA) [17]. The allantoic fluids
from infected eggs were collected 96 h post-inoculation
and virus titers were determined by hemagglutination
(HA) assay with 0.5% chicken RBC except in the case of
APMV-5, which was titrated by plaque assay on Vero
cells. The APMV-5 samples were inoculated in triplicate
onto 24-well plates of Vero cells at 80% confluency,
incubated for 1 h, washed with PBS, overlaid with 0.8%
methylcellulose, and observed for plaque production till
7 days post infection (dpi). The cells were fixed with
methanol and stained with 1% crystal violet. Values for
each tissue sample were based on average plaque count
from three wells. Vero cells were grown in Earle’s mini-
mum essential medium (EMEM) with 10% fetal bovine
serum (FBS). Chicken embryo fibroblast (DF-1) cells
were grown in Dulbecco’s minimal essential medium
(DMEM) containing 10% FBS at 37°C with 5% CO2.
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Preparation of hyperimmune antisera against viral
nucleocapsid (N) proteins in rabbits
For each of the prototype strains, virions were purified
on discontinuous sucrose gradients [12]. The viral pro-
teins were denatured and reduced and were separated
on 10% SDS-Polyacrylamide gels and negatively stained
using E-Zinc ™reversible stain kit (Pierce, Rockford, IL,
USA). Each serotype was analyzed on a separate gel to
avoid cross contamination. The N protein bands were
excised from the gels and destained with Tris-glycine
buffer, pH 8. The excised gel bands were minced in a
clean pestle and mixed with elution buffer (50 mM
Tris-HCl buffer pH 8, 150 mM NaCl, 0.5 mM EDTA,
5 mM DTT and 0.1% SDS) and transferred to the upper
chambers of Nanosep centrifugal device (Pall Life
Sciences, Ann Arbor, MI, USA). The proteins were
eluted by centrifugation at 13000 × g for 5 minutes, and
the eluted proteins were quantified and 200 μg of each
protein was mixed in complete Freund’s adjuvant and
injected subcutaneously into a rabbit. After two weeks, a
booster immunization was given with 200 μg of protein
in incomplete Freund’s adjuvant and two weeks later the
hyperimmune sera were collected. The sera were tested
by western blot and were found to recognize specifically
the homologous N protein (data not shown). The sera
were stored at -80°C until further use.
Experimental infection of hamsters
To study viral replication and pathogenicity, fifty seven
4-week-old Syrian golden hamsters (Charles River
Laboratories Inc, Wilmington, MA, USA) were housed
in negative-pressure isolators under Bio Safety Level
(BSL)-2 conditions and provided feed and water ad libi-
tum. The animals were cared for in accordance with the
Animal Welfare Act and the Guide for Care and Use of
Laboratory Animals and the protocols were approved by
the institution’s IACUC. Hamsters in groups of six were
inoculated intranasally with 100 μL of infectious allan-
toic fluid containing 28 HAU of each individual APMV,
except for APMV-5, which contained 3 × 103 PFU/mL,
under isoflurane anesthesia. A group of three hamsters
served as uninfected controls and were mock infected
with normal allantoic fluid. The hamsters were observed
three times daily for physical activity and for any clinical
signs of illness, and were weighed on day 0, 5 and
14 dpi. Three hamsters from each group were eutha-
nized at 3 dpi and the other three (as well as the three
animals in the control group) at 14 dpi by rapid asphyx-
iation in a CO2 chamber. Necropsies were performed
immediately postmortem and the following tissue
samples were collected for immunohistochemistry
(IHC), histopathology, and virus isolation: brain, nasal
turbinates, lung, spleen, kidney and small intestine.
In addition serum samples were collected on 14 dpi
immediately prior to euthanasia, and seroconversion was
evaluated by HI assay [46].
Virus detection and quantification from tissue samples
Half of each tissue sample was used for virus titration.
These samples were collected aseptically in 1 mL of
DMEM in 10X antibiotic solution containing 2000
units/mL penicillin, 200 ug/mL gentamicin sulfate, and
4 ug/mL amphotericin B (Sigma chemical co., St. Louis,
MO, USA). They were processed immediately to avoid
any reduction in virus titers. Briefly, a 10% homogenate
of the tissue samples were prepared by using a homoge-
nizer and clarified by centrifugation at 420 × g for
10 min. For all of the serotypes except APMV-5, the
virus titers in the clarified supernatants were determined
by end-point dilution on DF-1 cells. Tenfold dilutions of
tissue supernatant were inoculated onto DF-1 cells in
96-well plates and incubated for three days. The plates
were fixed in 10% formalin for 30 min and the cells
were permeabilized using 2% Triton X-100 for 2 min.
The plates were washed five times with PBS to remove
any residual formalin in the wells. The cells were
blocked using 2% normal goat serum for 60 min and
the plates were washed twice with PBS- Tween-20
(PBS-T). The cells were incubated with primary rabbit
antiserum raised against the N protein of the homolo-
gous APMV serotype at room temperature for 1 h. The
plates were washed with PBS twice, 5 min each. The
cells were incubated with anti rabbit FITC antibody as
secondary antibody for 45 min and washed finally with
PBS twice, 5 min each. The slides were visualized and
the virus titers were determined by end point titration
method using the Reed and Muench formula, and were
photomicrographed using a fluorescent microscope
(Zeiss Axioshop 2000, Zeiss, Göttingen, Germany) [47].
The virus titers in the supernatants of tissue homoge-
nates from APMV-5 infected hamsters were determined
by plaque assay in Vero cells as described above using
10-fold dilution series. Values for each tissue sample
were based on average plaque count from three wells.
Immunohistochemistry (IHC) and histopathology
The other half of each tissue sample was used for IHC
and histopathology. The tissues were fixed in 10% neu-
tral buffered formalin, held for approximately seven
days, and processed for IHC and histopathology. Paraffin
embedded 5-micron sections of all the tissue samples
were prepared at Histoserve, Inc. (Maryland, MD, USA).
The sections were stained with hematoxylin and eosin
for histopathology. Sections were also immunostained to
detect viral N protein using the following protocol.
Briefly, the tissue sections were deparaffinized in two
changes of xylene for 5 min each, hydrated in two
changes of 100% ethanol for 3 min each, changes of
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95% and 80% ethanol for 1 min each, and finally washed
in distilled water. The sections were processed for anti-
gen retrieval in a water bath containing sodium citrate
buffer (10 mM citric acid, 0.05% Tween 20, pH 6.0), at
95-100°C for 40 min and then allowed to cool to room
temperature for another 60 min. The sections were
rinsed in PBS-Tween 20, twice for 2 min each. The sec-
tions were blocked with 2% BSA in PBS for 1 h at room
temperature. The sections were then incubated with a
1:500 dilution of the homologous primary N-specific
rabbit antiserum in PBS for 1 h in a humidified cham-
ber. After three washes in PBS, the sections were incu-
bated with the secondary antibody (FITC conjugated
goat anti-rabbit antibody) for 30 min. After a further
wash cycle, the sections were mounted with glycerol
and viewed under an immunofluorescence microscope.
Serological analysis
Sera were collected from all the hamsters on 14 dpi
and evaluated for seroconversion by HI assay [46],
except in the case of APMV-5. In addition, cross-HI
tests were performed to investigate cross reactivity
with other APMV serotypes. Since APMV-5 does not
cause hemagglutination of chicken RBC, the antibody
titer was determined by plaque reduction neutraliza-
tion assay. Briefly, the sera were heat inactivated at
56°C for 30 min. Ten-fold dilutions of sera were made
and mixed with a constant amount of APMV-5 (3 ×
103 PFU), and incubated at room temperature for 1 h
in a shaker. The antigen antibody mixtures were ana-
lyzed by plaque assay as described above. The serum
titer that reduced plaque numbers by 70% was the end
point titer.
Results
Clinical disease and gross pathology
Four-week-old hamsters in groups of six were inocu-
lated by the intranasal route with 28 HA units of each
of the APMV serotypes except APMV-5, which was
administered at a dose of 3 × 103 PFU/mL. Three ani-
mals were sacrificed at day 3 and the remaining three
animals were sacrificed on day 14; following sacrifice,
the animals were processed for gross pathology, histo-
pathology, IHC, quantitative virology, and seroconver-
sion. Three uninfected animals served as controls and
were sacrificed and processed on day 14. All of the ani-
mals were observed three times daily and weighed daily.
None of the hamsters infected with any of the APMV
serotypes showed any visible clinical signs of disease
except those infected with APMV-9. All the six ham-
sters infected with APMV-9 serotype were dull and had
rough skin coat at 3 dpi. They appeared weak and lost
weight (Table 1) till 5 dpi, but later gained body weight
and appeared normal by 10 dpi. None of the hamsters
died of disease. The uninfected control hamsters
appeared healthy and normal.
Following sacrifice on days 3 and 14, the followings
organs were removed and examined for gross pathology,
histopathology, immunohistochemical analysis, and
quantitative virology: brain, lungs, nasal turbinates, small
intestine, kidney and spleen. Gross pathologic findings
were limited to the lungs of hamsters inoculated with
APMV-2 (Figure 1a) and APMV-3 (Figure 1b), and were
observed only at 3 dpi. In APMV-2-infected hamsters,
the entire pulmonary parenchyma was wet, glistening
and edematous, with some areas of reddening due to
congestion and hemorrhages. There were several diffuse
small round shaped red foci on the lungs. Similar gross
pathology was also seen in the lungs of APMV-3
infected hamsters, but with foci that were five times lar-
ger than those seen in APMV-2 infected hamsters. No
such gross lesions were observed in the hamsters of the
other infected groups at 3 dpi. There were no gross
visceral pathologic lesions in any of the infected ham-
sters at 14 dpi. No lesions were detected in the unin-
fected control hamsters.
Table 1 Body weights (in grams) of hamsters infected with APMV serotypes 1 to 9, measured on 0, 5 and 14 days post
inoculation (dpi)
APMV 0 dpi 5 dpi 14 dpi Body weight difference at 5 dpi
Control 79 ± 0.58 83 ± 0.58 89 ± 0.58 +4.82
APMV-1 75.8 ± 0.17 71 ± 0.58 74.3 ± 1.20 -6.33
APMV-2 77 ± 1.15 75.3 ± 0.3 79.3 ± 0.67 -2.22
APMV-3 78.3 ± 1.2 77.3 ± 2.69 80 ± 2.89 -1.33
APMV-4 77.6 ± 0.88 80.6 ± 0.67 84.67 ± 0.33 +3.72
APMV-5 82.3 ± 1.45 83.33 ± 1.67 90 ± 1.15 +1.2
APMV-6 77 ± 0.56 72.33 ± 1.45 80.33 ± 0.33 -6.45
APMV-7 77 ± 0.58 72.67 ± 1.78 74 ± 1 -5.96
APMV-8 78.3 ± 1.20 72.33 ± 1.45 75.3 ± 1.45 -8.26
APMV-9 78 ± 1.15 66.33 ± 0.67 80 ± 2.89 -17.59
Mean values with standard error are shown. The values of the difference in body weight at 5 dpi are calculated relative to day 0 for the same group and are
expressed in percentage gain (+) or loss (-).
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Histopathology
Histopathological lesions at 3 dpi were observed in the
nasal turbinates and lungs in all of the infected groups
(Figure 2, and data not shown). Figure 2e and 2f show
representative examples of the nasal turbinates for
APMV-9 and -3, respectively. The most predominant
histopathological lesions observed in the nasal turbinates
were multifocal necrotic/apoptotic epithelial cells and
nuclear pyknosis. Along the nasal septum were areas of
epithelial necrosis, accumulation of nuclear debris in the
mucosal epithelium, vacuolation of epithelial cells, and
blunting or loss of cilia. Small numbers of mononuclear
cells and neutrophils multifocally infiltrated the nasal
mucosa, with transcytosis and exocytosis into the nasal
cavity. There were small accumulations of inflammatory
cells and necrotic cellular debris in the nasal cavity.
Examples of lung tissue are shown for APMV-1
(Figure 2a and 2b), -2 (Figure 2c), and -7 (Figure 2d).
All the lung samples from the infected groups exhibited
interstitial bronchopneumonia of varying severity at
3 dpi. The inflammatory cell infiltrates were mixed
populations of lymphocytes, macrophages, and neutro-
phils. Additionally, bronchiolar and type II pneumocyte
hyperplasia in areas of inflammation with variable
degrees of cellular atypia were noticed and the degree of
cellular atypia was quite prominent. There were no his-
topathologic findings for any other organs (brain, small
intestine, kidney, and spleen) from any infected ham-
sters on day 3, or for any of the hamsters at 14 dpi.
Immunohistochemistry
Deparaffinized sections of the virus-infected and unin-
fected control tissue (brain, lungs, nasal turbinates,
small intestine, kidney, and spleen) were immunostained
using polyclonal antisera against the N protein of the
homologous APMV serotypes. Remarkably, animals
infected with APMV-5 did not show any positive immu-
nofluorescence in any of the tissues examined at 3 or
14 dpi. In animals infected with any of the other APMV
serotypes, virus-specific antigens were detected on 3 dpi
in the lungs and nasal turbinates (Figure 3). In the nasal
turbinates, virus-positive immunofluorescence was
noticed throughout the nasal epithelium lining the tur-
binate bone, and the harderian gland located near the
eye showed complete diffuse fluorescence throughout
the organ. In the lungs, the viral antigens were mostly
localized in the epithelium surrounding the medium
and small bronchi. Viral N antigens were not detected
in any additional organs of infected hamsters at 3 dpi,
and were not detected in any of the organs of infected
hamsters at 14 dpi. The organs of uninfected control






Figure 1 Gross pathology in lungs from hamsters 3 dpi with
APMV-2 (a) and -3 (b). (a) Lungs from a hamster infected with
APMV-2, showing multifocal mottling with petechial hemorrhages
(black arrow). (b) Lungs from a hamster infected with APMV-3,
showing multifocal areas of consolidation (white arrow) and
ecchymotic hemorrhage (black arrow). (c) Lungs from a mock
infected hamster (control).
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Figure 2 Representative histopathologic lesions in sections of lung (a-d) and nasal turbinates (e, f) from hamsters 3 dpi with APMV-1
(a, b), APMV-2 (c), APMV-7 (d) and APMV-9 (e, f). Lungs (g) and nasal turbinates (h) from uninfected hamster. (hematoxylin and eosin
staining, magnification, ×400). (a) Section of lung infected with APMV-1. The bronchiolar and bronchial epithelia are multifocally hyperplastic
(yellow arrow) and contain sloughed cellular debris and inflammatory cells (black arrow). There are moderate numbers of necrotic cells in the
bronchiolar epithelium and in areas of inflammation in alveoli. (b) Section of lung infected with APMV-1. There is multifocal infiltration and
consolidation of the pulmonary interstitium by moderate numbers of lymphocytes, monocytes, and neutrophils (black arrow), with an
accumulation of inflammatory cells in alveoli (yellow arrow). Multifocally, alveoli are lined by rows of hyperplastic epithelial cells (white arrows)
that sometimes exhibit cellular atypia, including anisocytosis, anisokaryosis, and cytomegaly (atypical type II pneumocyte hyperplasia). (c) Section
of lung infected with APMV-2. The pulmonary interstitium is multifocally infiltrated by moderate numbers of lymphocytes, monocytes, and
neutrophils (white arrows). (d) Section of lung infected with APMV-7. The pulmonary interstitium is multifocally infiltrated and consolidated by
moderate numbers of lymphocytes, monocytes, and neutrophils (black arrow), with accumulations of inflammatory cells in alveoli. Multifocally,
alveoli are lined by rows of hyperplastic epithelial cells (white arrow), with some areas exhibiting cellular atypia, including anisocytosis,
anisokaryosis, and cytomegaly (atypical type II pneumocyte hyperplasia). The bronchiolar and bronchial epithelia are multifocally hyperplastic
(yellow arrow). There are moderate numbers of necrotic cells in bronchiolar epithelium and in areas of inflammation in alveoli. (e) Section of
nasal turbinate infected with APMV-9. There is massive cell death and necrosis of the epithelial tissue lining the turbinate bone (white arrow).
There is no appreciable level of inflammatory cells in the surrounding tissues. (f) Section of nasal turbinate infected with APMV-3, showing
necrotic tissue, loss of ciliary tissue, and blunting of cilia (white arrow). (g) Section of lung from a mock infected hamster (control). (h) Section of
nasal turbinate from a mock infected hamster (control).
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Figure 3 Immunofluorescence localization of viral N antigen in sections of nasal turbinates (a, b), harderian glands (c, d) and lungs
(e, f) from hamsters 3 dpi with APMV-9 (a), APMV-1 (b), APMV-9 (c), APMV-8 (d), APMV-3 (e), and APMV-2 (f). Nasal turbinates (g) and
lung (h) from a representative uninfected control hamster (magnification, ×400). (a) Section of nasal turbinate infected with APMV-9.
Immunofluorescence was evident in the ciliated epithelium lining the turbinate bone (white arrows). (b) Section of nasal turbinate infected with
APMV-1. Immunofluorescence was evident primarily at the apical surface of the ciliated epithelial cells and in the cytoplasm (white arrows). (c)
Section of harderian gland infected with APMV-9. Immunofluorescence was evident primarily in the collecting ducts of the gland and also in the
cytoplasm of the infected cells (white arrows). (d) Section of harderian gland and nasal turbinate infected with APMV-8. Immunofluorescence
was evident primarily the cytoplasm of the infected cells in the harderian gland (white arrows) and in the epithelial cells lining the turbinates
(yellow arrows). (e) Section of the lung infected with APMV-3. Immunofluorescence was evident around the bronchial epithelium (white arrows).
(f) Section of lung infected with APMV-2. Immunofluorescence was mainly evident around the bronchiolar epithelium (white arrows). (g) Section
of nasal turbinate from a mock infected hamster (control). (h) Section of lung from a mock infected hamster (control).
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Virus isolation and titration in tissue samples
To analyze sites of virus replication, several organs
(brain, lungs, nasal turbinate, small intestine, kidney and
spleen) were collected on 3 and 14 dpi, for virus isola-
tion and titration. For all of the APMV serotypes except
APMV-5, titration was performed in DF-1 cells and the
titers were expressed in TCID50/g tissue; for APMV-5,
titration was by plaque assay in Vero cells (Table 2).
Virus was detected for a number of APMV serotypes
on 3 dpi; no virus was detected in any sample for any
serotype on 14 dpi. APMV-1 was isolated from lungs
and nasal turbinates of all three animals, with mean
titers of 1.7 × 103 and 1 × 103, respectively. APMV-2
was isolated from lungs (3/3 animals) and nasal turbi-
nates (2/3 animals), with mean titers of 4.1 × 103 and
5.3 × 103, respectively. APMV-3 was isolated from lungs
and nasal turbinates of all three animals, with mean
titers of 5.3 × 102 and 3.6 × 104, respectively. APMV-4
was isolated from lungs and nasal turbinates of all
three animals, with mean titers of 1.7 × 102 and 4.2 ×
103, respectively, and from the kidneys of one animal
(1 × 101). APMV-6 was isolated from the lungs and
nasal turbinates of all three animals, with mean titers of
2.6 × 103 and 7 × 101, respectively, and from the spleen
(1 animal, 3 × 101) and small intestine (1 animal, 3 ×
101). APMV-9 was isolated from the nasal turbinates
only from all three animals, with a mean titer of 2.5 ×
105. No virus was isolated from any tissues of the ham-
sters infected with APMV-5, -7 and -8. Also, no virus
was isolated from the brain of any hamsters infected
with APMV-1 to -9.
Serology
The virus replication in the hamsters infected with
APMVs was further investigated by measuring serocon-
version 14 dpi. Sera were analyzed by HI assay using
chicken erythrocytes (Table 3) in the case of all of the
serotypes except APMV-5, which was analyzed by pla-
que reduction assay. The HI titers of the pre-infection
hamsters were 2 or less. All HI titers greater than 8
were considered positive. Our results showed that all of
the infected hamsters seroconverted at 14 dpi, indicating





Lung Brain Spleen Kidney Small
Intestine
APMV-1 1 3 × 103 2 × 103 – – – –
2 2.4 × 103 3 × 103 – – – –
3 4 × 103 1 × 102 – – – –
APMV-2 1 9.29 × 103 1.7 × 103 – – – –
2 3.4 × 103 6.6 × 102 – – – –
3 3.5 × 103 - – – – –
APMV-3 1 3 × 104 4 × 102 – – – –
2 4.06 × 104 5.5 × 102 – – – –
3 3.75 × 104 6.6 × 102 – – – –
APMV-4 1 2 × 103 3 × 102 – – – –
2 2 × 103 1 × 101 – – 1 × 101 –
3 2 × 102 2 × 102 – – – –
APMV-5 1 – – – – – –
2 – – – – – –
3 – – – – – –
APMV-6 1 1 × 102 3 × 103 – – – 3 × 101
2 1 × 101 4 × 103 – – – –
3 1 × 102 1 × 103 – 3 × 101 – –
APMV-7 1 – – – – – –
2 – – – – – –
3 – – – – – –
APMV-8 1 – – – – – –
2 – – – – – –
3 – – – – – –
APMV-9 1 3 × 105 – – – – –
2 1.5 × 105 – – – – –
3 3.8 × 105 – – – – –
The virus titer values are expressed in TCID50 per gram of the indicated tissue sample.
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replication by all APMV serotypes. The mean HI titers
in hamsters for APMV-1, -2, -3, -4, -6, -7, -8, -9 were
1:256, 1:512, 1:512, 1:32, 1:64, 1:64, 1:1024, 1:256,
respectively. The mean serum antibody titer of APMV-5
as determined by virus plaque neutralization test was
found to be 1:256. The antigenic relationship among
APMV serotypes was evaluated by reciprocal HI tests
using these sera, which represent convalescent sera
obtained by a single infection of hamsters via the intra-
nasal route. Each of the antisera exhibited very high HI
titer against the homologous serotype and either no or
very low HI titer against heterologous serotypes, with
the exception of APMV -1 and APMV-9 (Table 3). The
antiserum specific for APMV-1 and APMV-9 exhibited
substantial cross-reactivity, although the APMV-1-speci-
fic antiserum had a four-fold higher titer against
APMV-1 than against APMV-9, and the APMV-9 speci-
fic antiserum had a two-fold higher titer against APMV-
9 than against APMV-1. These reactions indicated the
existence of antigenic relatedness between APMV-1 and
APMV-9.
Discussion
APMVs are frequently isolated from a wide variety of
avian species and are grouped into nine serotypes based
on antigenic reactions [48]. APMV-1 (NDV) is the most
extensively characterized member of the APMV sero-
types. APMV-2 to -9 have been isolated from both wild
and domestic birds, but their disease potential in wild or
domestic birds is largely unknown. APMV-1 has also
been shown to infect a number of non avian species
[41] and presently is being evaluated as a potential
human vaccine vector for human pathogens [45]. There-
fore, there is a possibility that APMV -2 to -9 could also
be used as human vaccine vectors for human pathogens.
However, the ability of APMV-2 to -9 to replicate in
mammalian hosts was unknown.
Hence, we have investigated the replication and patho-
genicity of APMV-1 to -9 in hamsters inoculated intra-
nasally. The intranasal route was intended to resemble
the natural route of APMV infection as well as a likely
route for vaccine vector administration. In this study,
hamsters were chosen as the mammalian animal model
because they are widely used to study replication and
pathogenesis of a variety of viruses such as adenovirus
[49], herpes virus [50], Nipah virus [51], human RSV
[52], human parainfluenza viruses, SARS virus [53], and
Eastern equine encephalitis [54].
Clinical disease was not evident with most of the
APMV serotypes, and was observed only in the case of
APMV-9. All of the animals infected with APMV-9
exhibited clinical disease including weakness and sub-
stantial weight loss. Only APMV-2 and -3 produced
gross pathological lesions in the lungs, whereas in ham-
sters infected with the other APMV serotypes the
appearance of the lungs was unremarkable. No gross
pathology was evident for any other organs with any of
the serotypes.
Virus was recovered from animals infected with
APMV-1, -2, -3, -4, -6, and -9. In all cases, virus was
isolated 3 dpi: no virus was detected in any samples for
any serotype 14 dpi. The viral titers were moderate and
were mostly restricted to the lungs and nasal turbinates;
there were isolated incidences of isolation from the
spleen (APMV-6), small intestine (APMV-6), or kidneys
(APMV-4). No virus was recovered from any tissue
from animals infected with APMV-5, -7 and -8. How-
ever, the lungs and nasal turbinate tissues from animals
infected with APMV-7 and -8 were positive by IHC,
indicating that these viruses infected and replicated at a
level that was below detection by our assays for quanti-
tative virology. Although APMV-5 was not detected by
virus isolation or by IHC in any of the tissues, all of the
animals that were inoculated with APMV-5 developed
Table 3 Cross-reactivity of sera from hamsters infected with the indicated APMV serotype (top) against the indicated
APMV serotype (left column)*
SERUM
APMV-1 APMV-2 APMV-3 APMV-4 APMV-5 APMV-6 APMV-7 APMV-8 APMV-9
VIRUS APMV-1 1:256 0 0 0 0 0 0 0 1:128
APMV-2 0 1:512 0 0 0 0 0 0 0
APMV-3 0 0 1:512 0 0 0 0 1:8 1:4
APMV-4 1:8 0 0 1:32 0 0 0 0 1:4
APMV-5 0 0 0 0 1:256 0 0 0 0
APMV-6 0 0 0 0 0 1:64 0 0 0
APMV-7 0 0 0 0 0 0 1:64 0 0
APMV-8 0 0 0 0 0 0 0 1:1024 0
APMV-9 1:64 0 0 0 0 0 0 0 1:256
*Sera were harvested 14 dpi. Cross-reactivity was measured by HI assay except when tested against APMV-5, in which case a plaque neutralization assay was
used. HI titers represent the highest dilution that displayed HI activity, and are expressed in mean HI units. For APMV-5, the 70% plaque reduction titer is shown
as the mean.
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titers of APMV-5 specific antibodies detected by virus
plaque reduction neutralization assay, indicating a low
level of replication. By 14 dpi, no virus could be
detected in any of the tissues in any the infected ham-
sters for any serotype, whether by histopathology, histo-
chemistry, or virus isolation. This suggests that the virus
was cleared from all tissues and disease was resolved,
indicating the self-limited nature of the infections. Simi-
lar results have been obtained from chickens infected
with APMV-2, -3 and -4, where no virus could be iso-
lated at 14 dpi [30].
Using IHC, viral N antigen was detected in the same
tissues that were positive by virus isolation. An interest-
ing finding was the presence of large amounts of viral
antigens at the epithelial cell linings, suggesting that
these cells are highly permissive to APMV replication.
In addition, the detection of viral antigens, and in most
cases infectious virus, in nasal turbinates and lungs of
the hamsters indicate that APMV replication is mostly
restricted to the respiratory tract. These results show
that all APMV serotypes are capable of infecting ham-
sters using a nasal route of infection and the extensive
amount of virus replication in the respiratory tract was
not accompanied by severe disease in hamsters.
Serologic assays demonstrated a humoral response in
all the hamsters inoculated with APMV serotypes -1 to
-9, a further indication of successful virus replication.
Our results show that all APMVs (except APMV-5,
which does not hemagglutinate) produced HI antibody
titers that varied between 1:32 to 1:1024. Based on the
HI titers, APMV-8 (1:1024) produced maximum anti-
body titer and APMV-4 (1:32) produced the least. Para-
doxically, while APMV-8 induced the highest titer of HI
antibodies, the virus could not be isolated from any of
the infected hamsters. Conversely, APMV-4 replicated
efficiently in hamsters as observed by virus isolation in
nasal turbinates, lungs and kidneys, but produced low
levels of virus-specific HI antibodies. Whether these
examples of incongruity between levels of replication
and serum antibody responses are indicative of differ-
ences in the antigenicity of the respective HN proteins
or to some other factor remains to be determined.
Warke et al. [30] have also provided evidence of low
HI titers in the case of APMV-4, in chickens, which was
taken as evidence of a low level of replication of this
virus in chickens. The HI test is the most commonly
used method to diagnose APMV infections and also is
used to measure the antibody response. But chicken
antiserum against NDV cross-reacts in HI tests with
several of the other APMV serotypes, thus questioning
the specificity of HI test in field cases [55]. Warke et al.
[38] indicated that the HI test lacks sensitivity for
detecting infection with these APMV serotypes. They
also observed that even in the case of a high infectious
dose and observed microscopic changes in the infected
organs, high HI titers were not observed in the infected
birds. On the contrary in our study, most of the APMV
serotypes replicated well in hamsters, producing mild
respiratory pathology and high neutralizing antibody
titers. Our results indicated that the antibody developed
in hamsters against these serotypes were very specific
and no cross reaction was observed between serotypes
except between APMV-1 and -9. Cross-reactivity
between these two serotypes is not completely unantici-
pated, since they share the highest level of genome
nucleotide sequence identity (58%) among the APMV
serotypes [12]. Hence, we conclude that the HI test with
hamster serum is highly specific and can be used to
diagnose different APMV serotypes in field cases.
The replication of APMVs in hamsters produced mild
rhinitis and mild pathology that was mainly restricted to
the respiratory tract. There was a concern that APMVs
may also replicate in the intestine and shed in feces,
which might act as a source of infection for the other
animals. But our results indicated that none of the
APMVs replicate in the intestinal epithelial cells of ham-
sters. Importantly, our results also suggest that these
viruses do not cross the blood-brain barrier and do not
induce neurological symptoms. Also, our previous
experimental studies of all the APMVs in chickens
showed that they were avirulent. Taken together, these
results show that the APMVs replicate moderately in
hamsters and produce either mild or no clinical signs,
and elicit substantial antibody responses. Therefore, it is
possible that APMVs might replicate in other mamma-
lian species including humans. In conclusion, this study
is the first comparative report on the replication and
pathogenicity of prototype strains of all 9 APMV sero-
types in hamsters. Our results lay the foundation for a
good laboratory animal model for testing the replication
and pathogenicity of APMV strains.
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